A minimally invasive capsule-string device reliably collected spatially resolved microbiome samples from the esophagus, stomach, duodenum, and jejunum in healthy adults, revealing distinct microbial signatures across upper GI compartments without requiring endoscopy.
Key Findings
Results
The capsule-string device was well tolerated and consistently recovered sufficient biomass from all four upper GI regions.
Sampling targeted the esophagus, stomach, duodenum, and jejunum during natural transit of the capsule
Anatomical localization of compartment-level samples was achieved using pH, bile staining, and string length measurements
The device enabled collection of both luminal and mucosal material from each compartment
Recovery of sufficient biomass was described as consistent across all upper GI regions sampled
Results
Distinct microbial community signatures were evident across upper GI compartments, with the strongest differences observed between proximal and small-intestinal regions.
The greatest differences in microbial communities were observed between proximal compartments (esophagus and stomach) and small-intestinal compartments (duodenum and jejunum)
Microbial communities were profiled using 16S rRNA gene sequencing
Regional microbial differences were characterized as 'distinct microbial signatures' across compartments
The spatial variation in communities was detectable across all four anatomical regions studied
Results
Individual host identity exerted the dominant influence on overall microbial community structure, but a reproducible regional signal persisted after accounting for between-person variation.
Between-person variation was identified as the primary driver of overall community structure
A reproducible regional (compartment-level) microbial signal was retained even after controlling for individual host effects
This finding indicates that anatomical location within the upper GI tract contributes a consistent, site-specific microbial signature independent of host identity
The study population consisted of healthy adults
Results
The capsule-string device provides reliable access to spatially resolved upper GI microbiota without requiring endoscopy.
Existing sampling methods rely on invasive endoscopy or stool, which 'poorly reflects the upper gut'
The capsule-string approach is described as minimally invasive and operates during natural GI transit
The method collected material from four distinct anatomical compartments in a single procedure
The authors characterize the approach as enabling 'more precise mapping of gut microbial organization in vivo'
Discussion
The capsule-string sampling approach creates new opportunities for longitudinal, mechanistic, and disease-focused studies of host-microbiome interactions in upper GI regions that have historically been inaccessible.
Upper GI regions have been described as 'historically inaccessible' to non-endoscopic microbiome sampling
The device enables compartment-level resolution not achievable with stool-based profiling
The authors identify potential applications in longitudinal and disease-focused study designs
The approach is positioned as enabling mechanistic studies of host-microbiome interactions in the upper gut
What This Means
This research suggests that a swallowable capsule attached to a thin string can safely and effectively collect microbiome samples from four different regions of the upper digestive tract — the esophagus, stomach, duodenum, and jejunum — in healthy adults, all without the need for an invasive endoscopy procedure. By analyzing which bacteria were present in each region using genetic sequencing, the researchers found that different parts of the upper gut harbor meaningfully different communities of microorganisms, with the biggest differences seen between the stomach and the small intestine. While each person's individual biology had the strongest overall effect on what microbes were found, there was still a consistent location-based pattern that showed up across participants, meaning the sampling method reliably captured real anatomical differences rather than just random variation.
This matters because most of what scientists know about the human gut microbiome comes from stool samples, which primarily reflect the large intestine and do not give good information about the upper digestive tract. Yet the upper gut — including the stomach and small intestine — plays important roles in digestion, nutrient absorption, and immune function. Until now, studying the microbiome in these regions required endoscopy, a procedure that involves sedation and carries some risk, making large-scale or repeated sampling impractical. This new capsule-string device offers a much less invasive alternative that could make it feasible to study upper gut microbiomes in larger groups of people, track changes over time, or investigate how these microbial communities are altered in diseases affecting the upper digestive tract.